2nd Basic & Clinical Immunology Course
Five days of immunology lectures at Universiti Malaya in July 2017, led by Professor Shiv Pillai of Harvard Medical School and Professor Liew Foo Yew of the University of Glasgow.
· Training · Supported by Prima Nexus
About the course
The course took place from 5 to 9 July 2017 in Auditorium T.J. Danaraj at the Faculty of Medicine, Universiti Malaya, Kuala Lumpur. It was organised by the university's Department of Medical Microbiology and Department of Parasitology. Its aim was to extend knowledge of recent developments in immunology. The five-day programme was designed for biomedical students, clinicians, academics and scientists who wanted extensive knowledge and skills in immunology and its use in research and therapy.
What the programme covered
The lectures covered the molecules, mediators and cells behind immune responses: MHC, antigen receptors and co-stimulatory molecules; cytokines, chemokines and hormones; and T and B lymphocytes, antigen-presenting cells and innate cells. The focus was on immune responses against infectious diseases, cancer, autoimmunity and allergy. Participants received handouts of the lectures and a certificate of participation.
Professor Shiv Pillai of Harvard Medical School is one of the authors of the textbook Cellular and Molecular Immunology. His research includes the use of the immune system to treat cancer and new therapies for chronic diseases such as arthritis and lupus. Professor Liew Foo Yew of the University of Glasgow is known for his work on T cell heterogeneity and on the role of nitric oxide in regulating the immune system.
The role of Prima Nexus
Prima Nexus supported the course. Researchers who study cytokines, chemokines and other immune mediators can measure them today through the Prima Nexus ELISA and Luminex testing service.
More of our work with UM.
Read the story: Prima Nexus supported immunology, infection and cancer research meetings at Universiti Malaya and UPM in 2017.
About Prima Nexus
Founded in 2014, Prima Nexus Sdn Bhd is a Malaysian research, scientific consulting and integrated research support company advancing scientific discovery and healthcare innovation. We provide end-to-end research solutions, from early-stage discovery and experimental design to cell-based studies, preclinical animal testing, clinical trials and commercialization. Our multidisciplinary expertise spans genomics, genetic applications, proteomics, molecular biology, stem cell research, bioinformatics and clinical research. Through strategic collaborations with universities, research institutions, industry and global technology partners, we connect scientific expertise and advanced technologies to accelerate research into real-world applications. We also run hands-on training for researchers across Malaysia. More about Prima Nexus.
